ArticleCancers2022
Do We Need TNM for Tracheal Cancers? Analysis of a Large Retrospective Series of Tracheal Tumors.
Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 15 citations in OpenAlex.
- Complete Response to Chemo-Immunotherapy in Recurrent Unresectable Tracheal Squamous Cell Carcinoma: A Case Report.Cureus · 2026Article
- Impact of combined endoscopic therapy on progression-free survival in patients with primary tracheal cancers: a multivariate-adjusted retrospective cohort study.Respiratory research · 2025Article
- Real-world oncologic outcomes of thoracoscopic and open tracheal cancer resection.Journal of thoracic disease · 2025Article
- Diagnosis and multimodality treatment of primary malignant tracheal tumors.Translational cancer research · 2025Review
- Tracheal squamous cell carcinoma treated with tracheal resection and anastomosis in a dog.The Canadian veterinary journal = La revue veterinaire canadienne · 2025Article
- Primary malignant tumors of the trachea: a retrospective analysis of the clinical data of 79 patients treated in a single center.Frontiers in oncology · 2025Article
- Treatment outcomes of patients with primary tracheal tumors - analysis of a large retrospective series.BMC cancer · 2024Article
- Clinicopathological characteristics of patients with primary tracheal tumors: Analysis of eighty-nine cases.Thoracic cancer · 2024Review
- Adenoid cystic carcinoma of distal trachea: A case report.Clinical case reports · 2024Article
- Tracheal cancer: a rare and deadly but potentially curable disease that also affects younger people.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to the low incidence of primary tracheal neoplasms, there is no uniform system for staging of this disease. Our retrospective analysis based on registry data included 89 patients diagnosed with primary tracheal cancer at the National Research Institute of Oncology in Warsaw, Poland, between January 2000 and December 2016. We analyzed demographic, clinical, pathological, therapeutic, and survival data. The staging-for the purpose of our analysis-was performed retrospectively on the basis of imaging results. Tumor (T) category was defined as a disease confined to the trachea or lesion derived from the trachea and spreading to adjacent structures and organs. Node (N) and metastases (M) categories were divided into absence/presence of metastasis in regional lymph nodes and the absence/presence of distant metastasis. Survival analysis was performed depending on the clinical presentation of these features. There was a significant difference in overall survival depending on the T, N, M categories in the entire group. In the group of patients undergoing radical treatment, the T and N categories had a statistically significant impact on overall survival. In the group of patients treated with palliative aim, only the T category had an impact on overall survival. Multivariate analysis showed statistical significance for the T category in patients undergoing radical and those receiving palliative treatment. The assessment of the anatomical extent of lesions may help decide about treatment options and prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.